1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Cell Lysis/Cell Fractionation Market by Product, Instruments, Type of Cell, End User - Global Forecasts to 2021

The cell lysis market is expected to reach USD 3.84 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.3%. The global cell lysis market is segmented based on product, type of cell, end-users, and regions. The consumables segment is expected to register the highest growth rate in the cell lysis market, by product, during the forecast period. The high growth in this segment is attributed to the increasing investments in research.

Based on end-users, the cell lysis market is segmented into research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the market in 2016. Increasing prevalence of diseases and the need for development of new therapies will drive the growth of this market.

Geographically, the cell lysis market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by increasing aging population, and rising government funding in the North American countries.

The major factors contributing to the growth of the cell lysis market include increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine. Furthermore, increasing R&D spending and new product development activities by companies is another major factor driving the growth of this market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.

The major players in this market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the product portfolios of the top players in the cell lysis market. The report analyses the cell lysis market by product, type of cell, end-users, and regions
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the cell lysis market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell lysis market
- Market Development: Comprehensive information about emerging markets. This report analyses the market for various cell lysis market products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell lysis market

Table Of Contents

Cell Lysis/Cell Fractionation Market by Product, Instruments, Type of Cell, End User - Global Forecasts to 2021
TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 14
1.3.1 MARKET SEGMENTATION 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 16
1.5 LIMITATION 16
1.6 MARKET STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.3 MARKET SHARE ESTIMATION 21
2.4 KEY DATA FROM SECONDARY SOURCES 22
2.5 KEY DATA FROM PRIMARY SOURCES 23
2.6 KEY INDUSTRY INSIGHTS 24
2.7 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 CELL LYSIS MARKET OVERVIEW 29
4.2 CELL LYSIS MARKET, BY PRODUCT 30
4.3 CELL LYSIS MARKET, BY TYPE OF CELL 31
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL LYSIS MARKET 32
4.5 GEOGRAPHIC ANALYSIS: CELL LYSIS MARKET, BY END USER 33
4.6 LIFECYCLE ANALYSIS, BY REGION, 2016 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 CELL LYSIS MARKET, BY PRODUCT 36
5.2.2 CELL LYSIS MARKET, BY TYPE OF CELL 36
5.2.3 CELL LYSIS MARKET, BY END USER 37
5.2.4 CELL LYSIS MARKET, BY REGION 37

5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 38
5.3.1.1 Increasing government funding for research 38
5.3.1.2 High prevalence of diseases 39
5.3.1.3 Expanding biotechnology and biopharmaceutical industries 40
5.3.1.4 Growing focus on personalized medicine 40
5.3.2 RESTRAINTS 41
5.3.2.1 High cost of cell-based research 41
5.3.2.2 Shortage of skilled personnel 41
5.3.3 OPPORTUNITIES 42
5.3.3.1 Emerging countries to present high-growth opportunities 42
5.3.4 CHALLENGES 43
5.3.4.1 Survival of small players and new entrants 43
6 CELL LYSIS MARKET, BY PRODUCT 44
6.1 INTRODUCTION 45
6.2 CONSUMABLES 46
6.2.1 REAGENTS AND KITS 47
6.2.1.1 Enzymes 49
6.2.1.2 Detergent solutions 50
6.2.1.3 Other reagents and kits 50
6.2.2 BEADS 51
6.2.3 DISPOSABLES 52
6.3 INSTRUMENTS 53
6.3.1 SONICATORS 55
6.3.2 HOMOGENIZERS 57
6.3.3 OTHER INSTRUMENTS 58
7 CELL LYSIS MARKET, BY TYPE OF CELL 60
7.1 INTRODUCTION 61
7.2 MAMMALIAN CELLS 62
7.3 MICROBIAL CELLS 64
7.4 OTHER CELLS 66
8 CELL LYSIS MARKET, BY END USER 68
8.1 INTRODUCTION 69
8.2 RESEARCH LABORATORIES AND INSTITUTES 70
8.3 BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 71
8.4 OTHERS 73

9 CELL LYSIS MARKET, BY REGION 75
9.1 INTRODUCTION 76
9.2 NORTH AMERICA 78
9.2.1 U.S. 82
9.2.2 CANADA 84
9.3 EUROPE 86
9.4 ASIA 91
9.5 ROW 95
10 COMPETITIVE LANDSCAPE 98
10.1 OVERVIEW 98
10.2 MARKET SHARE ANALYSIS 99
10.3 COMPETITIVE SITUATION AND TRENDS 100
10.3.1 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS 101
10.3.2 ACQUISITION 102
10.3.3 NEW PRODUCT LAUNCHES 103
10.3.4 EXPANSION 104
10.3.5 OTHER DEVELOPMENTS 104
11 COMPANY PROFILES 105
11.1 INTRODUCTION 105
11.2 THERMO FISHER SCIENTIFIC, INC. 106
11.3 MERCK KGAA 109
11.4 BIO-RAD LABORATORIES, INC. 113
11.5 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) 115
11.6 BECTON, DICKINSON AND COMPANY 118
11.7 CELL SIGNALING TECHNOLOGY, INC. 120
11.8 MILTENYI BIOTEC 121
11.9 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 123
11.10 QIAGEN N.V. 125
11.11 QSONICA, LLC 127
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
12 APPENDIX 128
12.1 INSIGHTS OF INDUSTRY EXPERTS 128
12.2 DISCUSSION GUIDE 129
12.3 AVAILABLE CUSTOMIZATIONS 131
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 132
12.5 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 133
12.6 RELATED REPORTS 135


LIST OF TABLES

TABLE 1 BIOTECHNOLOGY RandD EXPENDITURE, BY COUNTRY 39
TABLE 2 RISING INCIDENCES OF DISEASES 39
TABLE 3 EXPANDING BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES AND HIGH PREVALENCE OF DISEASES ARE DRIVING THE CELL LYSIS MARKET 41
TABLE 4 HIGH COST OF CELL LYSIS PRODUCTS IS EXPECTED TO RESTRAIN MARKET GROWTH 42
TABLE 5 ASIAN ECONOMIES TO CREATE NEW GROWTH OPPORTUNITIES IN THE MARKET 42
TABLE 6 SURVIVAL OF SMALL PLAYERS AND NEW ENTRANTS IS A MAJOR CHALLENGE IN THE CELL LYSIS MARKET 43
TABLE 7 CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 45
TABLE 8 CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY REGION,
2014-2021 (USD MILLION) 46
TABLE 9 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY COUNTRY, 2014-2021 (USD MILLION) 47
TABLE 10 CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 47
TABLE 11 CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY REGION,
2014-2021 (USD MILLION) 48
TABLE 12 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS,
BY COUNTRY, 2014-2021 (USD MILLION) 48
TABLE 13 CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE,
2014-2021 (USD MILLION) 49
TABLE 14 CELL LYSIS MARKET SIZE FOR ENZYMES, BY REGION, 2014-2021 (USD MILLION) 49
TABLE 15 CELL LYSIS MARKET SIZE FOR DETERGENT SOLUTIONS, BY REGION,
2014-2021 (USD MILLION) 50
TABLE 16 CELL LYSIS MARKET SIZE FOR OTHER REAGENTS AND KITS, BY REGION,
2014-2021 (USD MILLION) 51
TABLE 17 CELL LYSIS MARKET SIZE FOR BEADS, BY REGION, 2014-2021 (USD MILLION) 51
TABLE 18 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR BEADS, BY COUNTRY,
2014-2021 (USD MILLION) 52
TABLE 19 CELL LYSIS MARKET SIZE FOR DISPOSABLES, BY REGION,
2014-2021 (USD MILLION) 52
TABLE 20 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR DISPOSABLES, BY COUNTRY, 2014-2021 (USD MILLION) 53
TABLE 21 CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY REGION,
2014-2021 (USD MILLION) 54
TABLE 22 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY COUNTRY, 2014-2021 (USD MILLION) 54
TABLE 23 CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 55
TABLE 24 CELL LYSIS MARKET SIZE FOR SONICATORS, BY REGION,
2014-2021 (USD MILLION) 56
TABLE 25 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR SONICATORS, BY COUNTRY, 2014-2021 (USD MILLION) 56
TABLE 26 CELL LYSIS MARKET SIZE FOR HOMOGENIZERS, BY REGION,
2014-2021 (USD MILLION) 57
TABLE 27 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR HOMOGENIZERS, BY COUNTRY, 2014-2021 (USD MILLION) 57
TABLE 28 CELL LYSIS MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION,
2014-2021 (USD MILLION) 58
TABLE 29 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR OTHER INSTRUMENTS,
BY COUNTRY, 2014-2021 (USD MILLION) 59
TABLE 30 CELL LYSIS MARKET SIZE, BY TYPE OF CELL, 2014-2021 (USD MILLION) 62
TABLE 31 MAMMALIAN CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 63
TABLE 32 NORTH AMERICA: MAMMALIAN CELLS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 63
TABLE 33 MICROBIAL CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 65
TABLE 34 NORTH AMERICA: MICROBIAL CELLS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 65
TABLE 35 OTHER CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 66
TABLE 36 NORTH AMERICA: OTHER CELLS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 67
TABLE 37 CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 69
TABLE 38 CELL LYSIS MARKET SIZE FOR RESEARCH LABORATORIES and INSTITUTES,
BY REGION, 2014-2021 (USD MILLION) 70
TABLE 39 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR RESEARCH LABORATORIES and INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION) 71
TABLE 40 CELL LYSIS MARKET SIZE FOR BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION) 72
TABLE 41 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION) 72
TABLE 42 CELL LYSIS MARKET SIZE FOR OTHER END USERS, BY REGION,
2014-2021 (USD MILLION) 73
TABLE 43 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION) 74
TABLE 44 CELL LYSIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 77
TABLE 45 NORTH AMERICA: CELL LYSIS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 78
TABLE 46 NORTH AMERICA: CELL LYSIS MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 79
TABLE 47 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 80
TABLE 48 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE, 2014-2021 (USD MILLION) 80
TABLE 49 NORTH AMERICA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 81
TABLE 50 NORTH AMERICA: CELL LYSIS MARKET SIZE, BY CELL TYPE,
2014-2021 (USD MILLION) 81
TABLE 51 NORTH AMERICA: CELL LYSIS MARKET SIZE, BY END USER,
2014-2021 (USD MILLION) 81
TABLE 52 U.S.: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 82
TABLE 53 U.S.: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 82
TABLE 54 U.S.: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 83
TABLE 55 U.S.: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION) 83
TABLE 56 U.S.: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 83
TABLE 57 CANADA: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 84
TABLE 58 CANADA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 84
TABLE 59 CANADA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 85
TABLE 60 CANADA: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION) 85
TABLE 61 CANADA: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 86
TABLE 62 EUROPE: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 88
TABLE 63 EUROPE: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 89
TABLE 64 EUROPE: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE,
2014-2021 (USD MILLION) 89
TABLE 65 EUROPE: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 90
TABLE 66 EUROPE: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION) 90
TABLE 67 EUROPE: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 90
TABLE 68 ASIA: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 92
TABLE 69 ASIA: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 93
TABLE 70 ASIA: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE,
2014-2021 (USD MILLION) 93
TABLE 71 ASIA: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 94
TABLE 72 ASIA: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION) 94
TABLE 73 ASIA: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 94
TABLE 74 ROW: CELL LYSIS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 95
TABLE 75 ROW: CELL LYSIS MARKET SIZE FOR CONSUMABLES, BY TYPE,
2014-2021 (USD MILLION) 96
TABLE 76 ROW: CELL LYSIS MARKET SIZE FOR REAGENTS AND KITS, BY TYPE,
2014-2021 (USD MILLION) 96
TABLE 77 ROW: CELL LYSIS MARKET SIZE FOR INSTRUMENTS, BY TYPE,
2014-2021 (USD MILLION) 96
TABLE 78 ROW: CELL LYSIS MARKET SIZE, BY CELL TYPE, 2014-2021 (USD MILLION) 97
TABLE 79 ROW: CELL LYSIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 97
TABLE 80 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016 101
TABLE 81 ACQUISITIONS, 2013-2016 102
TABLE 82 NEW PRODUCT LAUNCHES, 2013-2016 103
TABLE 83 EXPANSIONS, 2013-2016 104
TABLE 84 OTHER DEVELOPMENTS, 2013-2016 104


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 TOP-DOWN APPROACH 19
FIGURE 3 BOTTOM-UP APPROACH 19
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 5 DATA TRIANGULATION METHODOLOGY 21
FIGURE 6 CELL LYSIS MARKET SIZE, BY PRODUCT (2016 VS. 2021): CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET 25
FIGURE 7 MAMMALIAN CELLS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE CELL LYSIS MARKET DURING THE FORECAST PERIOD 26
FIGURE 8 RESEARCH LABORATORIES AND INSTITUTES END-USER SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 27
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE CELL LYSIS MARKET, 2016 28
FIGURE 10 CELL LYSIS MARKET TO SHOWCASE HIGH GROWTH OPPORTUNITIES IN THE FORECAST PERIOD 29
FIGURE 11 CONSUMABLES SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD MARKET 30
FIGURE 12 MAMMALIAN CELLS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE
IN 2016 31
FIGURE 13 U.S. TO COMMAND ONE-THIRD OF THE MARKET IN 2016 32
FIGURE 14 RESEARCH LABORATORIES AND INSTITUTES SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 33
FIGURE 15 ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE CELL LYSIS MARKET DURING THE FORECAST PERIOD 34
FIGURE 16 CELL LYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 17 CONSUMABLES SEGMENT TO DOMINATE THE CELL LYSIS PRODUCTS MARKET DURING THE FORECAST PERIOD 45
FIGURE 18 SONICATORS SEGMENT WILL GROW AT HIGHEST CAGR DURING THE FORECAST PERIOD 53
FIGURE 19 MAMMALIAN CELLS SEGMENT EXPECTED TO DOMINATE THE MARKET IN THE FORECAST PERIOD 61
FIGURE 20 NORTH AMERICA EXPECTED TO DOMINATE THE MICROBIAL CELLS MARKET DURING THE FORECAST PERIOD 64
FIGURE 21 RESEARCH LABORATORIES and INSTITUTES SEGMENT ACCOUNTED FOR THE LARGEST SHARE IN 2016 69
FIGURE 22 ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET DURING THE FORECAST PERIOD 71
FIGURE 23 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 76
FIGURE 24 ASIA - AN ATTRACTIVE MARKET FOR CELL LYSIS 77
FIGURE 25 NORTH AMERICA: MARKET SNAPSHOT 79
FIGURE 26 EUROPE: MARKET SNAPSHOT 87
FIGURE 27 EUROPE: ESTIMATED NUMBER OF NEW CANCER CASES 88
FIGURE 28 ASIA: MARKET SNAPSHOT 92
FIGURE 29 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, THE KEY GROWTH STRATEGIES FOR MARKET PLAYERS 98
FIGURE 30 GLOBAL CELL LYSIS MARKET SHARE, BY KEY PLAYER, 2015 99
FIGURE 31 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATION WERE THE PREFERRED STRATEGIES FOR MARKET PLAYERS 100
FIGURE 32 PRODUCT BENCHMARKING FOR TOP 5 MARKET PLAYERS 105
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 106
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT 109
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 113
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT 115
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 118
FIGURE 38 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 123
FIGURE 39 QIAGEN N.V.: COMPANY SNAPSHOT 125
FIGURE 40 MARKETSANDMARKETS KNOWLEDGE STORE SNAPSHOT 133
FIGURE 41 MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT 134

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

Global Biopharmaceuticals Market Growth, Trends & Forecasts (2016 - 2021)

Global Biopharmaceuticals Market Growth, Trends & Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • September 2016
  • by Mordor Intelligence LLP

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the yea ...

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

  • $ 2995
  • Industry report
  • September 2016
  • by Currentpartnering

The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the co-development deals and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.